These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 18753474

  • 21. Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke.
    Arenillas JF, Ispierto L, Millán M, Escudero D, Pérez de la Ossa N, Dorado L, Guerrero C, Serena J, Castillo J, Dávalos A.
    Neurology; 2008 Jul 15; 71(3):190-5. PubMed ID: 18625965
    [Abstract] [Full Text] [Related]

  • 22. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M, Shuaib A, Alexandrov AV, Sebastian J, Khan K, Uchino K.
    Int J Stroke; 2015 Oct 15; 10(7):1087-92. PubMed ID: 26332252
    [Abstract] [Full Text] [Related]

  • 23. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S, McWilliams-Dunnigan L, Blackham KL, Kirchner HL, Sundararajan S, Sunshine JL, Tarr RW, Selman WR, Landis DM, Suarez JI.
    J Stroke Cerebrovasc Dis; 2008 Sep 15; 17(5):266-72. PubMed ID: 18755405
    [Abstract] [Full Text] [Related]

  • 24. Recanalization within one hour after intravenous tissue plasminogen activator is associated with favorable outcome in acute stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Aoki J, Watanabe M, Kobayashi K, Sakamoto Y.
    Eur Neurol; 2010 Sep 15; 63(6):331-6. PubMed ID: 20516694
    [Abstract] [Full Text] [Related]

  • 25. Time to recanalization and risk of symptomatic intracerebral haemorrhage in patients treated with intravenous thrombolysis.
    Dorado L, Millán M, Pérez de la Ossa N, Guerrero C, Gomis M, Aleu A, López-Cancio E, Cuadras P, Dávalos A.
    Eur J Neurol; 2012 Sep 15; 19(9):1251-5. PubMed ID: 22568604
    [Abstract] [Full Text] [Related]

  • 26. Residual flow at the site of intracranial occlusion on transcranial Doppler predicts response to intravenous thrombolysis: a multi-center study.
    Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Shuaib A, Alexandrov AV, CLOTBUST Investigators.
    Cerebrovasc Dis; 2009 Sep 15; 27(1):5-12. PubMed ID: 19018132
    [Abstract] [Full Text] [Related]

  • 27. Safety and feasibility of a lower dose intravenous TPA therapy for ischemic stroke beyond the first three hours.
    Uchino K, Alexandrov AV, Garami Z, El-Mitwalli A, Morgenstern LB, Grotta JC.
    Cerebrovasc Dis; 2005 Sep 15; 19(4):260-6. PubMed ID: 15731557
    [Abstract] [Full Text] [Related]

  • 28. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T, Hanumanthu R, Khandelwal P.
    J Stroke Cerebrovasc Dis; 2019 Nov 15; 28(11):104360. PubMed ID: 31501036
    [Abstract] [Full Text] [Related]

  • 29. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Nov 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T, Minematsu K.
    Brain Nerve; 2009 Sep 15; 61(9):1003-12. PubMed ID: 19803399
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study.
    Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV.
    Stroke; 2003 Mar 15; 34(3):695-8. PubMed ID: 12624293
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete].
    García-García J, Gracia-Gil J, Sopelana-Garay D, Ayo-Martín O, Vadillo-Bermejo A, Touza B, Peñalver-Pardines C, Zorita MD, Segura T.
    Rev Neurol; 2003 Mar 15; 46(1):7-12. PubMed ID: 18214820
    [Abstract] [Full Text] [Related]

  • 37. Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography--guided pilot study.
    Sekoranja L, Loulidi J, Yilmaz H, Lovblad K, Temperli P, Comelli M, Sztajzel RF.
    Stroke; 2006 Jul 15; 37(7):1805-9. PubMed ID: 16763175
    [Abstract] [Full Text] [Related]

  • 38. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.
    Cerebrovasc Dis; 2008 Jul 15; 26(2):126-33. PubMed ID: 18560215
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).
    Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Garami Z, Barreto A, Spengos K, Forteza A, Mikulik R, Sharma VK, Brunser A, Martinez P, Montaner J, Kohrmann M, Schellinger PD, Alexandrov AV, CLOTBUST-PRO Investigators.
    Int J Stroke; 2008 Feb 15; 3(1):66-72. PubMed ID: 18705918
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.